All articles by Praveen Duddu

1. ESMO 2019: Seven promising digital health intervention companies participating in ESMO

   Digital health interventions (DHIs) are fast emerging as vital tools to promote personal health and provide essential services. DHIs can…
   Read More…

   26 Sep
2. Infectious diseases on Twitter: Ebola leads mentions in August 2019

   Pharmaceutical Technology lists the top tweeted terms in infectious diseases in August 2019, based on data from GlobalData’s Influencer Platform….
   Read More…

   20 Sep
3. Metabolic disorders on Twitter: Diabetes leads mentions in August 2019

   Pharmaceutical Technology lists the top tweeted terms on metabolic disorders in August 2019, based in data from Global Data’s Influencer…
   Read More…

   19 Sep
4. Deals this week: Vistin Pharma, Shenzhen Neptunus Bioengineering

   Vistin Pharma plans to raise up to Nkr300m ($38.82m) in gross proceeds through a private placement of shares of its common…
   Read More…

   23 Mar
5. M&As this week: Otsuka Pharmaceutical Factory, Shin Kowa Pharmaceutical

   Otsuka Pharmaceutical Factory has reached an agreement with Mitsui & Co to acquire a remaining 20% interest in Otsuka Pharmaceutical India…
   Read More…

   23 Mar
6. Deals and M&As this week: Zydus Cadila Healthcare, Eisai, Tabuk Pharmaceuticals Manufacturing Company

   Zydus Cadila Healthcare has signed an agreement with Medicure’s subsidiary Medicure International for the commercialisation of its ZYPITAMAG (pitavastatin magnesium) drug,…
   Read More…

   9 Mar
7. Deals this week: ExpreS2ion Biotech Holding, Arbutus Biopharma, Intrexon

   ExpreS2ion Biotech Holding, a biopharmaceutical company based in Denmark, intends for a rights offering of 2,400,403 shares at a price…
   Read More…

   19 Jan
8. Deals this week: China Meheco, Recordati, Novartis

   China Meheco intends to form a Chinese pharmaceutical joint venture (JV) through its subsidiary with a capital of CNY10m ($1.51m). To…
   Read More…

   22 Dec
9. M&As this week: Strides Pharma Asia, GlaxoSmithKline

   Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company Trinity Pharma for R55m ($4.31m)….
   Read More…

   22 Dec
10. Report: Multiple sclerosis disease-modifying therapies market to witness CAGR of 2.9%

    Sales of multiple sclerosis (MS) disease-modifying therapies (DMTs) are projected to grow from $19.1bn in 2016 to $25.3bn in 2026,…
    Read More…

    15 Dec